Plasmodium Immunotherapy for Advanced Malignant Solid Tumors

NCT04165590 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Solid Tumor

Interventions

OTHER: Plasmodium immunotherapy

Sponsor

CAS Lamvac Biotech Co., Ltd.